Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Age-related macular degeneration (AMD) is the most common form of irreversible blindness in developed countries. Variants in the factor H gene (CFH, also known as HF1), which encodes a major inhibitor of the alternative complement pathway, are associated with the risk for developing AMD. Here we test the hypothesis that variation in genes encoding other regulatory proteins of the same pathway is associated with AMD. We screened factor B (BF) and complement component 2 (C2) genes, located in the major histocompatibility complex class III region, for genetic variation in two independent cohorts comprising approximately 900 individuals with AMD and approximately 400 matched controls. Haplotype analyses identify a statistically significant common risk haplotype (H1) and two protective haplotypes. The L9H variant of BF and the E318D variant of C2 (H10), as well as a variant in intron 10 of C2 and the R32Q variant of BF (H7), confer a significantly reduced risk of AMD (odds ratio = 0.45 and 0.36, respectively). Combined analysis of the C2 and BF haplotypes and CFH variants shows that variation in the two loci can predict the clinical outcome in 74% of the affected individuals and 56% of the controls. These data expand and refine our understanding of the genetic risk for AMD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This analysis resulted in the identification of the previously well documented independently associated variants near CFH and C2/CFB8,10,31,32 and of additional independent signals near C3, CETP, LIPC, FRK/COL10A1, IER3/DDR1, RAD51B (Supplementary Table 6).”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Genes in the complement pathway4–11 and a region of chromosome 10 12,13 have now been implicated as the major genetic contributors to disease.”
From Seven new loci associated with age-related macular degeneration (2013) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“These include complement 2 (C2) and/or complement factor B (CFB) (56), complement 3 (C3) (170), and complement factor I (CFI) (44).”
From Unraveling a Multifactorial Late-Onset Disease: From Genetic Susceptibility to Disease Mechanisms for Age-Related Macular Degeneration (2009) · cites this paper as [56]
In the citing paper
“studies have demonstrated that at least one of the two variants associated with AMD—R32Q BF—leads to an impairment in the complement activating function of BF (Gold et al., 2006).”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
In the citing paper
“the L9H BF/E318D C2 and R32Q BF/intronic variants of C2 have been shown to be protective for AMD (odds ratio (OR) = 0.45 and 0.36, respectively) by Gold et al.”
From Molecular pathology of age-related macular degeneration (2009) · cites this paper as Gold et al., 2006
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482 · cited 1×
“Overall type I error rates (α) were retrospectively calculated using a previously described metho”
MethodComplement factor H polymorphism in age-related macular degeneration
Klein, R. J., Zeiss, C., Chew, E. Y., Tsai, J.-Y., Sackler, R. S., Haynes, C., Henning, A. K., SanGiovanni, J. P., Mane, S. M., Mayne, S. T., et al. (2005) · Science · doi:10.1126/science.1109557 · Cited by 4,492
Complement factor H polymorphism and age-related macular degeneration
Edwards, A. O., Ritter, R., Abel, K. J., Manning, A., Panhuysen, C., & Farrer, L. A. (2005) · Science · doi:10.1126/science.1110189 · Cited by 2,449
Complement factor H variant increases the risk of age-related macular degeneration
Haines, J. L., Hauser, M. A., Schmidt, S., Scott, W. K., Olson, L. M., Gallins, P., Spencer, K. L., Kwan, S. Y., Noureddine, M., Gilbert, J. R., et al. (2005) · Science · doi:10.1126/science.1110359 · Cited by 2,424
Hageman, G. S., Anderson, D. H., Johnson, L. V., Hancox, L. S., Taiber, A. J., Hardisty, L. I., Hageman, J. L., Stockman, H. A., Borchardt, J. D., Gehrs, K. M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501536102 · Cited by 1,961
Self-citationBird, A. C., Bressler, N. M., Bressler, S. B., Chisholm, I. H., Coscas, G., Davis, M. D., de Jong, P. T. V. M., Klaver, C. C. W., Klein, B. E. K., Klein, R., et al. (1995) · Survey of Ophthalmology · doi:10.1016/s0039-6257(05)80092-x · Cited by 1,926
Hageman, G. (2001) · Progress in Retinal and Eye Research · doi:10.1016/s1350-9462(01)00010-6 · Cited by 1,265
Self-citationDrusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208
A Fine-Scale Map of Recombination Rates and Hotspots Across the Human Genome
Myers, S., Bottolo, L., Freeman, C., McVean, G., & Donnelly, P. (2005) · Science · doi:10.1126/science.1117196 · Cited by 1,134 · cited 1×
“Fourth, estimated recombination rates from HapMap data indicate regions of high recombination on both sides of the C2/BF locu”
BackgroundA role for local inflammation in the formation of drusen in the aging eye
Anderson, D. H., Mullins, R. F., Hageman, G. S., & Johnson, L. V. (2002) · American Journal of Ophthalmology · doi:10.1016/s0002-9394(02)01624-0 · Cited by 1,087
Self-citation
Cited by
Items 801–900 of 1,000
NEI-Supported Age-Related Macular Degeneration Research: Past, Present, and Future
Wright, C. B., Mazzucco, A. E., Becker, S. M., Sieving, P. A., & Tumminia, S. J. (2020) · Translational Vision Science & Technology · doi:10.1167/tvst.9.7.49 · Cited by 8
Analysis of the RDS/peripherin gene in age‐related macular degeneration
Baird, P. N., Richardson, A. J., Islam, A. F. M., Lim, L., & Guymer, R. H. (2007) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2007.01477.x · Cited by 9
“Recently, it has been shown that several genes play an important role in the pathogenesis of AMD (including the complement factor H gene, the Factor B gene and the complement component 2 gene).(2) However, other genes including VEGF, VLDLR and LRP6 have also been implicated in disease.”
BackgroundGenetic and Epigenetic Regulation in Age-Related Macular Degeneration
Wei, L., Chen, P., Lee, J. H., & Nussenblatt, R. B. (2013) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0b013e31829e2793 · Cited by 8
Mechanisms of Oxidative Stress in Retinal Injury
Brantley, M. A., & Sternberg, P. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00022-9 · Cited by 9
Genetics of Age-Related Macular Degeneration
Kasuga, D. T., Chen, Y., & Zhang, K. (2011) · Springer eBooks · doi:10.1007/978-1-4614-0125-4_1 · Cited by 9
“Further analysis showed a codominant model for these two haplotypes [44].”
BackgroundDoney, A. S. F., Leese, G., Olson, J., Morris, A. D., & Palmer, C. N. A. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02719.x · Cited by 7
Bardak, H., Bardak, Y., Erçalık, Y., Kumral, E. T., İmamoğlu, S., Günay, M., Özbaş, H., & Bağcı, Ö. (2016) · Genetics and Molecular Research · doi:10.4238/gmr15049164 · Cited by 7
Latest Development on Genetics of Common Retinal Diseases
Chen, L. J., Chen, Z. J., & Pang, C. P. (2023) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000592 · Cited by 7
Development of Novel Drugs for Ocular Diseases: Possibilities for Individualized Therapy
Lai, T. Y. Y., Chen, L. J., Yam, G. H., Tham, C. C. Y., & Pang, C. P. (2010) · Personalized Medicine · doi:10.2217/pme.10.25 · Cited by 7
Wolf-Schnurrbusch, U. E. K., Hess, R., Jordi, F., Stuck, A. K., Sarra, G., Wolf, S., & Enzmann, V. (2013) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2012.726393 · Cited by 7
Role of inflammation in the pathogenesis of age-related macular degeneration
Scholl, S., Kirchhof, J., & Augustin, A. J. (2009) · Expert Review of Ophthalmology · doi:10.1586/eop.09.51 · Cited by 7
Pathogenesis of Age-Related Macular Degeneration
Zarbin, M. A. (2012) · ESASO course series · doi:10.1159/000336763 · Cited by 9
Complement Factor I Gene Polymorphism in a Turkish Age-Related Macular Degeneration Population
Aygün, F. B., Kadayıfçılar, S., Özgül, R. K., & Eldem, B. M. (2019) · Ophthalmologica · doi:10.1159/000503327 · Cited by 7
Afshar‐Kharghan, V. (2009) · Biologics · doi:10.2147/btt.s2753 · Cited by 10
“Later on, associations between AMD and additional polymorphisms in the factor H gene, as well as polymorphisms in other complement proteins, were detected (Gold et al 2006; Hughes et al 2006; Li et al 2006; Maller et al 2006; Dinu et al 2007).”
Baas, D. C., Ho, L., Tanck, M. W. T., Fritsche, L. G., Merriam, J. E., Slot, R. V. ‘., Koeleman, B. P. C., Gorgels, T. G. M. F., van Duijn, C. M., Uitterlinden, A. G., et al. (2012) · PubMed Central · doi:10.5283/epub.35845 · Cited by 11
Self-citationNext-Generation Therapeutic Solutions for Age-Related Macular Degeneration
Cunnusamy, K., Ufret-Vincenty, R. L., & Wang, S. (2012) · Pharmaceutical Patent Analyst · doi:10.4155/ppa.12.12 · Cited by 8
Thomas, G., Grassi, M. A., Lee, J. R., Edwards, A. O., Gorin, M. B., Klein, R., Casavant, T. L., Scheetz, T. E., Stone, E. M., & Williams, A. B. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-1022 · Cited by 7
“22 If one were to envision the complexity of this ex-periment represented in graphic form, the data would appear the following way: more than 120 feature instances per expert plotted on five different attribute axes comprising more than 600 total data points for each expert.”
BackgroundPetrukhin, K. E. (2020) · Topics in medicinal chemistry · doi:10.1007/7355_2020_105 · Cited by 7
Ayub, H., Shafique, S., Azam, A., Muslim, I., Qazi, N. A., Akhtar, F., Khan, M. A., Ayub, A., Bashir, S., Bakker, B., et al. (2019) · Annals of Human Genetics · doi:10.1111/ahg.12311 · Cited by 7
“Other genes of the complement pathway have also been found to be associated with AMD, including C2/CFB and C3 (Gold et al., 2006).”
BackgroundWang, X., Shang, Q., Ma, J., Liu, S., Wang, C., & Ma, C. (2020) · International Journal of Ophthalmology · doi:10.18240/ijo.2020.03.03 · Cited by 8
Ning, G., Zhen, L., Xu, W., Li, X., Wu, L., Liu, Y., Xie, C., & Peng, L. (2020) · Journal of Viral Hepatitis · doi:10.1111/jvh.13319 · Cited by 7
Systemic changes in neovascular age-related macular degeneration.
Singh, A. (2014) · PubMed · Cited by 10
The role of molecular genetic factors in age-related macular degeneration
de Almeida, L. N. F., Melilo-Carolino, R., Sperandio, D. C., Nehemy, M. B., & Marco, L. D. (2009) · Arquivos Brasileiros de Oftalmologia · doi:10.1590/s0004-27492009000400027 · Cited by 10
Serum complement factor H and Tyr4O2 His gene polymorphism among Egyptians with multiple sclerosis
Rasol, H. A. A., Helmy, H., & Aziz, M. A. (2015) · Neurological Research · doi:10.1179/1743132815y.0000000075 · Cited by 8
10q26 Is Associated with Increased Risk of Age-Related Macular Degeneration in the Utah Population
Cameron, D. J., Yang, Z., Tong, Z., Zhao, Y., Praggastis, A., Brinton, E., Harmon, J. N., Chen, Y., Pearson, E., Bernstein, P. S., et al. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-74904-4_29 · Cited by 9
Salman, A., Song, W. K., Storm, T., McClements, M. E., & MacLaren, R. E. (2025) · Gene Therapy · doi:10.1038/s41434-025-00522-z · Cited by 6
Dry age-related macular degeneration and age-related macular degeneration pathogenesis
Zarbin, M. A., & Sunness, J. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-7020-2983-7.00068-1 · Cited by 8
Parsons, N., Annamalai, B., & Rohrer, B. (2023) · Translational Vision Science & Technology · doi:10.1167/tvst.12.7.17 · Cited by 6
Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis
Misicka, E., Huang, Y., Loomis, S. J., Sadhu, N., Fisher, E., Gafson, A., Runz, H., Tsai, E. A., Jia, X., Herman, A. H., et al. (2024) · Neurology Genetics · doi:10.1212/nxg.0000000000200159 · Cited by 6
“53 On closer review of the gene-based association results, 8/26 (vs 1200/19136) genes involved in complement system activation 54 were associated with AAO ( p < 0.05), which is a 6.61-fold enrichment (95% CI 2.88 – 15.16; p = 2.8 × 10 − 7 ) compared with the entire genome.”
BackgroundInfluentialComplement alternative pathway genetic variation and Dengue infection in the Thai population
Kraivong, R., Vasanawathana, S., Limpitikul, W., Malasit, P., Tangthawornchaikul, N., Botto, M., Screaton, G. R., Mongkolsapaya, J., & Pickering, M. C. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12184 · Cited by 9
Susceptibility Genes and Pharmacogenetics in Ocular Inflammatory Disorders
Liu, B., Sen, H. N., & Nussenblatt, R. B. (2012) · Ocular Immunology and Inflammation · doi:10.3109/09273948.2012.710706 · Cited by 7
“[37] Gold B, Merriam JE, Zernant J, et al.”
BackgroundDensen, P., & Ram, S. (2015) · Elsevier eBooks · doi:10.1016/b978-1-4557-4801-3.00009-6 · Cited by 6
The Role of Amyloid-β in Retinal Degeneration
Bruban, J., Dinet, V., & Mascarelli, F. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0631-0_10 · Cited by 7
Clegg, D., Buchholz, D. E., Hikita, S. T., Rowland, T. J., Hu, Q., & Johnson, L. V. (2008) · Springer eBooks · doi:10.1007/978-1-4020-8502-4_1 · Cited by 6
Age-related macular degeneration with discordant late stage phenotypes in monozygotic twins
Keilhauer, C. N., Fritsche, L. G., & Weber, B. H. F. (2011) · Ophthalmic Genetics · doi:10.3109/13816810.2011.592177 · Cited by 7
Dong, Y. N., Li, Z.-D., Fang, X., Shi, X., Chen, S., & Tang, X. (2015) · International Journal of Ophthalmology · doi:10.3980/j.issn.2222-3959.2015.02.31 · Cited by 6
Screening of DNA-variants in the properdin gene (CFP) in age-related macular degeneration (AMD)
Seitsonen, S., Onkamo, P., Torniainen, S., Ihalainen, M., Immonen, I., Meri, S., & Järvelä, I. E. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.01.001 · Cited by 7
Current Gene Discovery Strategies for Ocular Conditions
Duggal, P., Ibay, G., & Klein, A. P. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6989 · Cited by 6
Delrue, C., Speeckaert, R., & Speeckaert, M. M. (2026) · Biomolecules · doi:10.3390/biom16020234 · Cited by 5
“Similarly, polymorphisms in complement factor I (CFI), complement factor B (CFB), and complement component 2 (C2) influence complement regulation, either exacerbating or mitigating AMD risk depending on their functional consequences [20].”
Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern®
Wallace, D. K., Flaxel, C. J., Gedde, S. J., Jacobs, D. S., Kopplin, L. J., Lee, B. S., Mah, F. S., Oetting, T. A., Varu, D. M., & Musch, D. C. (2026) · Ophthalmology · doi:10.1016/j.ophtha.2025.12.031 · Cited by 6
Dunaief, D. M., Cwanger, A., & Dunaief, J. L. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-401717-7.00063-0 · Cited by 6
Genetik und Risikofaktoren der exsudativen AMD
Dietzel, M., Farwick, A., & Hense, H. (2010) · Der Ophthalmologe · doi:10.1007/s00347-010-2141-8 · Cited by 8
“des Komplementsystems (C3, C2/CFB; [8, 19]) sowie dem HTRA1-Gen, dessen Auftreten jedoch mit ARMS2 assoziiert ist, nachgewiesen werden [12, 30].”
BackgroundResponses of blood metabolites and proteins to different vitamin A levels in Korean native steers.
Wang, T., Lee, K., USuk, J., Jin, Y., Lee, S.-B., Lee, J., JinHee, H., JiNa, L., Kim, M., Choi, S., et al. (2014) · Pakistan Veterinary Journal · Cited by 5
Basic Mechanisms of Pathological Retinal and Choroidal Angiogenesis
Vavvas, D. G., & Miller, J. W. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00026-6 · Cited by 7
Martínez-Velasco, A., & Martínez-Villaseñor, L. (2018) · Lecture notes in computer science · doi:10.1007/978-3-030-02837-4_21 · Cited by 5
CoffeeProt: an online tool for correlation and functional enrichment of systems genetics data
Molendijk, J., Seldin, M. M., & Parker, B. L. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab352 · Cited by 5
“CoffeeProt identified previously characterized high-impact SNPs including rs4151667 and rs641153, resulting in non-synonymous L9H and R32Q variants of CFB, respectively (35,36).”
BackgroundRisikofaktoren der altersbedingten Makuladegeneration
Boltz, A., Lasta, M., Schmidl, D., KAYA, S., Garhöfer, G., & Schmetterer, L. F. (2010) · Spektrum der Augenheilkunde · doi:10.1007/s00717-010-0445-3 · Cited by 5
Wang, Y., Xie, M., Zhang, M., Zhao, X., Zhu, X., Wang, Y., Chen, Y., Chen, J., & Sun, X. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.785126 · Cited by 6
“About 75% of AMD patients in European and North American countries/regions have been reported to carry CFH and CFB/C2 variants (43).”
BackgroundProteomic characteristics of plasma and blood cells in natural aging rhesus monkeys
Wu, N., Xiao, F., Zhang, J., Chi, Y., Zhai, Y., Chen, B., & Lu, J. (2022) · PROTEOMICS · doi:10.1002/pmic.202200049 · Cited by 6
Autoimmunity: Homeostasis of Innate Immunity Gone Awry
Park, H. J., & Atkinson, J. P. (2012) · Journal of Clinical Immunology · doi:10.1007/s10875-012-9815-8 · Cited by 5
“The combined analyses of risk variants in members of the AP can account for nearly 75% of AMD cases [15,46].”
BackgroundAge-related macular degeneration (AMD): Current concepts in pathogenesis and prospects for treatment
Shin, O. R., & Kim, Y. H. (2013) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-012-0374-0 · Cited by 7
“2 C2, BF, C3, CFI Since CFH encodes an inhibitory protein in the complement cascade, studies on other complement regulators such as complement factor 2 (C2) and complement factor B (FB) have revealed their roles in the pathogenesis of AMD as well.(52) Whereas CFH inhibits the alternative pathway of the complement syst…”
BackgroundLiutkevičienė, R., Liutkevičius, V., Giedraitienė, A., Kriauciuniene, L., & Ašmonienė, V. (2017) · InTech eBooks · doi:10.5772/intechopen.70551 · Cited by 5
Chinchilla, B., Foltopoulou, P. F., & Fernández‐Godino, R. (2021) · The Journal of Pathology · doi:10.1002/path.5747 · Cited by 5
Age-Related Macular Degeneration
Storey, P. P., & Haller, J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815245-4.00003-x · Cited by 5
C3b and factor H: key components of the complement system
Jokiranta, T. S. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.5.775 · Cited by 5
Zipfel, P. F., & Lauer, N. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4118-2_11 · Cited by 6
Kotwal, G. J., Fernando, N., Zhou, J., & Valter, K. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.022 · Cited by 5
“…the complement ystem can modulate the susceptibility of individuals to the disease. o date, multiple genes have been linked to the disease, C2, CFB, CFH o mention a few (Gold et al., 2006; Edwards et al., 2005; Hageman t al., 2005; Gorin, 2005; Kuehn, 2005; Klein et al., 2005; Haines t al., 2005).”
BackgroundInflammation in age-related macular degeneration: pathological or physiological?
Yasukawa, T. (2009) · Expert Review of Ophthalmology · doi:10.1586/eop.09.1 · Cited by 5
Peng, H., & Hulleman, J. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163855 · Cited by 5
“The R32Q variant in CFB was also found to be protective along with the variant of intron 10 of C2 (rs547154) [43], as well as the R102G variant of C3 (rs2230199) and the V62I variant of CFH (rs800292) [47].”
BackgroundProgress in understanding and treating age-related macular degeneration
Lotery, A. J. (2008) · Eye · doi:10.1038/sj.eye.6703035 · Cited by 5
Infection, inflammation and age‐related macular degeneration
Kalayoglu, M. V., & Miller, J. W. (2007) · Clinical and Experimental Ophthalmology · doi:10.1111/j.1442-9071.2007.01432.x · Cited by 5
“In fact, a combined analysis of these variants predicts clinical outcome in nearly 75% of affected individuals.(5) Clearly, components of the complement pathway – a potent inflammatory defence mechanism against infection – are involved in the pathogenesis of AMD.”
BackgroundC3aR1-Deletion Delays Retinal Degeneration in a White-Light Damage Mouse Model
Behnke, V., Wolf, A., Hector, M., & Langmann, T. (2025) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.66.1.15 · Cited by 4
Huang, S., & Yin, H. (2025) · Biomedicines · doi:10.3390/biomedicines13020487 · Cited by 5
“Bert Gold et al. found that C2 single nucleotide polymorphisms were associated with age-related macular degeneration (AMD) [71].”
Amyloid and Neurodegeneration: Alzheimer's Disease and Retinal Degeneration
Prakasam, A., Venugopal, C., Suram, A., Pacheco‐Quinto, J., Zhou, Y., Pappolla, M. A., Sharpe, K. A., Lahiri, D. K., Greig, N. H., Rohrer, B. ̈., et al. (2008) · Springer eBooks · doi:10.1007/978-0-387-30375-8_7 · Cited by 4
Genetics in Age-Related Macular Degeneration: Current Research and Implications for Future Treatment
Broadhead, G., Chang, A., & McCluskey, P. (2012) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0b013e31826e1d4a · Cited by 4
“Conversely, the E318D polymorphism in the complement factor 2 (C2) gene, in combination with the L9H variant in the complement factor B (CFB) gene (E318D/ L9H), and the R32Q polymorphism in CFB have both been shown to be protective against AMD development.(20) These genes produce products with similar functionsV regul…”
BackgroundSoheilian, R., Bonyadi, M. H. J., Moein, H.-R., Babanejad, M., Ramezani, A., Yaseri, M., & Soheilian, M. (2016) · International Ophthalmology · doi:10.1007/s10792-016-0373-6 · Cited by 4
“Genetic predisposition with risk variants in the complement factor H (CFH) gene and complement pathway-associated genes (C2/BF) supports the inflammation role in AMD cases [3, 6, 7].”
BackgroundGenetic and environmental risk factors for extramacular drusen.
Altay, L., Subiras, X., Lorés‐Motta, L., Schick, T., Berghold, A., Hoyng, C. B., den Hollander, A. I., Fauser, S., Sadda, S. R., & Liakopoulos, S. (2020) · PubMed Central · Cited by 5
Complement Mediators in Development to Treat Age-Related Macular Degeneration
Nebbioso, M., Franzone, F., Lambìase, A., Taurone, S., Artico, M., Gharbiya, M., Greco, A., & Polimeni, A. (2022) · Drugs & Aging · doi:10.1007/s40266-021-00914-x · Cited by 5
Age-Related Macular Degeneration
Storey, P. P., Hark, L. A., & Haller, J. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-401717-7.00002-2 · Cited by 6
Rôles des chimiokines dans le développement de la dégénérescence maculaire liée à l’âge
Raoul, W., Lelièvre, E. C., Auvynet, C., Feumi, C., Combadière, C., & Sennlaub, F. (2010) · Biologie Aujourd hui · doi:10.1051/jbio/2010024 · Cited by 5
Free Radical Biology of Eye Diseases
Kisić, B., Miric, D. J., & Zoric, L. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_192 · Cited by 4
Cheng, S. N., & Leng, T. (2016) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/23258160-20160419-09 · Cited by 4
Animal Models for Age-Related Macular Degeneration
Hollyfield, J. G., & Kuttner-Kondo, L. A. (2009) · Neuromethods · doi:10.1007/978-1-60761-541-5_5 · Cited by 4
Абдулаева, Э. А. (2018) · Kazan medical journal · doi:10.17816/kmj2018-657 · Cited by 5
Age-related Macular Degeneration: Current Knowledge of Zinc Metalloproteinases Involvement
Liva, F., Cuffaro, D., Nuti, E., Nencetti, S., Orlandini, E., Vozzi, G., & Rossello, A. (2019) · Current Drug Targets · doi:10.2174/1389450120666190122114857 · Cited by 4
Lapchak, P. A., Butte, P. V., & Rajput, P. S. (2016) · Pan Stanford Publishing Pte. Ltd. eBooks · doi:10.1201/9781315364827-39 · Cited by 4
Bench-to-Bedside Research in Ophthalmology
Gupta, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-8845-4_5 · Cited by 5
Salman, A., McClements, M. E., & MacLaren, R. E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031697 · Cited by 5
“…of C3 into C3a and C3b, and removes C3b from the C3aC3b complex, which downregulates the alternative pathway activity when activated excessively [13]. and complement component 3 ( C3 ) are among many other variants in the complement cascade that have also been associated with AMD [3,14,15].”
BackgroundThe Chromosome 10q26 Susceptibility Locus in Age-Related Macular Degeneration
Stanton, C. M., Chalmers, K. J., & Wright, A. F. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0631-0_47 · Cited by 4
Zhou, T., Guan, H. J., & Hu, J. (2015) · Genetics and Molecular Research · doi:10.4238/2015.december.21.13 · Cited by 4
“…include: ABCA4, CFH, EFEMP1, CFB, C2, RDS, VEGF, ELOVL4, CX3CR1, HTRA1, LOC387715, VMD2, APOE, and TIMP3 (Kanda et al., 2005; Klein et al., 2005; Gold et al., 2006; Fu et al., 2007; Leveziel et al., 2007; Spencer et al., 2007; Lin et al., 2008; Chen et al., 2012; Fritsche et al., 2012; Priya et…”
BackgroundOxidative Damage and Macular Degeneration
Khandhadia, S., Cree, A. J., & Lotery, A. J. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_171 · Cited by 5
Fleckenstein, M., Schmitz-Valckenberg, S., Sunness, J. S., & Holz, F. G. (2012) · Springer eBooks · doi:10.1007/978-3-642-22107-1_8 · Cited by 6
The SERPING1 gene and age-related macular degeneration
Klaver, C. C. W., & Bergen, A. A. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61349-5 · Cited by 4
Correction: Systemic Complement Activation in Age-Related Macular Degeneration
Scholl, H. P. N., Issa, P. C., Walier, M., Janzer, S., Pollok‐Kopp, B., Börncke, F., Fritsche, L. G., Chong, V. N., Fimmers, R., Wienker, T. F., et al. (2008) · PLoS ONE · doi:10.1371/annotation/511a1029-bc43-4510-a4ca-c1db31810acc · Cited by 4
Choroidal endothelial cell activation in age-related macular degeneration
Skeie, J. M. (2010) · doi:10.17077/etd.rqzkgl09 · Cited by 6
“Moreover, variants in other complement genes C2/CFB(126), C3(127), and SERPING1(128) have been reported in AMD patients .”
BackgroundHultgren, N. W., Petcherski, A., Torriano, S., Komirisetty, R., Sharma, M. B., Zhou, T., Burgess, B. L., Ngo, J., Osto, C. A., Shabane, B., et al. (2024) · PNAS Nexus · doi:10.1093/pnasnexus/pgae500 · Cited by 3
Epigenetic Alterations in Age-Related Macular Degeneration: Mechanisms and Implications
Kisswani, D., Carroll, C., Valdés‐Mora, F., & Rutar, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157601 · Cited by 3
“For instance, studies have investigated C3 [76,91], complement component 2 ( C2 ) [92], complement Factor B ( CFB ) [93], complement 7 ( C7 ) [94], cluster of differentiation 46 ( CD46 ) [95], and complement factor I ( CFI ) [96,97].”
Skerka, C., Cochlovius, B., Hüllebrand, J. P., Goel, D., Sood, P., Pal, N., Chakravarti, A., Muth, D. R., Zeitz, O., & Zipfel, P. F. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1814415 · Cited by 3
Zhang, M., & Baird, P. N. (2016) · Ophthalmic Genetics · doi:10.1080/13816810.2016.1227451 · Cited by 5
Roshanipour, N., Bonyadi, M. J., Bonyadi, M. H. J., & Soheilian, M. (2019) · Journal of Current Ophthalmology · doi:10.1016/j.joco.2019.07.005 · Cited by 3
“The presence of the minor allele (A allele) in the genotypes reduces the activity of the complement system and therefore has a probable protective impact against the AMD disease.(8) Several studies in the USA,(8,15) the Netherlands,(16,17) Spain,(18) and China(19) have shown significant association between L9H CFB wit…”
BackgroundResultInfluentialOverview of Risk Factors for Age-Related Macular Degeneration
Armstrong, R. A., & Cubbidge, R. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815245-4.00002-8 · Cited by 3
Lou, L., Hu, K., Jin, K., Zhang, S., & Ye, J. (2014) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2014.1752 · Cited by 3
Huang, L., Zhang, X., Tam, P. O. S., Chen, H., Hao, F., Pang, C., Wen, F., & Yang, Z. (2018) · Journal of Human Genetics · doi:10.1038/s10038-018-0490-3 · Cited by 3
Epidemiology and Risk Factors for Age-Related Macular Degeneration
Seddon, J. M., & Sobrin, L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0737-9.00063-1 · Cited by 6
Oguchi, Y., Sekiryu, T., Omori, T., Kato, Y., Ogasawara, M., Sugano, Y., Itagaki, K., Ojima, A., Machida, T., & Sekine, H. (2020) · Experimental Eye Research · doi:10.1016/j.exer.2020.108025 · Cited by 3
The exhaustive genomic scan approach, with an application to rare-variant association analysis
Kanoungi, G., Nothnagel, M., Becker, T., & Drichel, D. (2020) · European Journal of Human Genetics · doi:10.1038/s41431-020-0639-3 · Cited by 3
“Interestingly, a previous study found a positive correlation between the HLA-B allele HLA-B27 with AAMD [22].”
ResultInfluentialIdentifying X-chromosome variants associated with age-related macular degeneration
Grunin, M. A., Igo, R. P., Song, Y. E., Blanton, S. H., Pericak‐Vance, M. A., & Haines, J. L. (2024) · Human Molecular Genetics · doi:10.1093/hmg/ddae141 · Cited by 3
Complement Pathways and Oxidative Stress in Models of Age-Related Macular Degeneration
Rohrer, B., Bandyopadhyay, M., Kunchithapautham, K., & Thurman, J. M. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-606-7_2 · Cited by 3
“In addition, since the original report on CFH as a risk factor, variations in the genes for CFB , C2 , and C3 [ 35, 36 ] , as major risk factors have also been reported.”
BackgroundAge-related Macular Degeneration—Review and Current Concepts
Seth, R. K., Sigler, E. J., Adelman, R. A., & Resident, C. (2011) · touchREVIEWS in Ophthalmology · doi:10.17925/usor.2011.04.01.96 · Cited by 3
“The apparent importance of genes involved in the complement cascade has led to further studies and identification of several additional candidate genes, including complement component 2.(43)”
BackgroundReview of Emerging Treatments for Age-Related Macular Degeneration
Zarbin, M. A., & Rosenfeld, P. J. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-606-7_1 · Cited by 3
Metadata
- Authors
- The AMD Genetics Clinical Study Group, Gold, B., Merriam, J. E., Zernant, J., Hancox, L. S., Taiber, A. J., Gehrs, K., Cramer, K., Neel, J., Bergeron, J., Barile, G. R., Smith, R. T., Hageman, G. S., Dean, M., & Allikmets, R.
- Affiliations
- National Cancer Institute (US)
- Columbia University (US)
- University of Iowa (US)
- Science Applications International Corporation (United States) (US)
- Corresponding author
- Dean, Michael
- Allikmets, Rando
- ORCID
- Venue
- Nature Genetics
- Published
- 2006-03-05
- Volume
- 38
- Issue
- 4
- Pages
- 458-462
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- PMC
- PMC2921703
- OpenAlex
- W1997288094
- Cited by
- 1,075
- References
- 31
- Citations by year
- 2026: 17 · 2025: 17 · 2024: 18 · 2023: 17 · 2022: 27 · 2021: 40 · 2020: 33 · 2019: 28 · 2018: 27 · 2017: 31 · 2016: 47 · 2015: 65 · 2014: 74 · 2013: 69 · 2012: 90
- FWCI
- 85.56
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Eye Institute (EY11515, R01EY013435, EY-13435, R01EY015520, R01EY011515)
- National Cancer Institute (N01-CO-124000)
- Topics
- Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
- Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- age-related macular degeneration, factor B, alternative complement pathway, genetic risk variants, haplotypes, complement factor H, MHC class III, genetic susceptibility
- MeSH terms
- Aged, Aged, 80 and over, Aging, Chromatography, High Pressure Liquid, Complement C2, Haplotypes, Humans, Immunohistochemistry, Macular Degeneration, Molecular Sequence Data, Complement Factor B, Cohort Studies, Case-Control Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.